Saturday, November 1, 2014

10 Best Safest Stocks To Buy Right Now

Research by NSS Labs indicates that in its testing, Microsoft� (NASDAQ: MSFT  ) �Internet Explorer and Google� (NASDAQ: GOOG  ) �Chrome are the safest browsers.

NSS, which bills itself as "the world's leading information security research and advisory company," recenlty unveiled the results of its Browser Security Comparative Analysis: Socially Engineered Malware. Over the course of 28 days, from March 13 through April 9, the firm tested the five, most popular browsers against 754 samples of real-world malicious software. The browsers were�Apple� (NASDAQ: AAPL  ) Safari 5,�Google�Chrome 25/26, Microsoft�Internet Explorer 10, Mozilla Firefox 19, and Opera 12.

The results revealed significant safety differences.

Blocking technologies used by browsers (higher is better).
Source: NSS-Browser Security Comparative Analysis

Top 5 Beverage Companies To Own For 2015: Teck Resources Ltd(TCK)

Teck Resources Limited operates as a diversified mining, mineral processing, and metallurgical company. It is involved in exploring, developing, smelting, refining, safety, environmental protecting, product stewardship, recycling, and researching activities. The company offers zinc and lead concentrates, and copper and molybdenum concentrates; zinc and lead, and alloys in a range of compositions and shapes; specialty metals, such as germanium, indium, and cadmium; and precious metals, including refined silver and gold dore. It also provides materials comprising low alpha lead materials, as well as delivers low alpha tin and copper electroplating anodes for semiconductors and integrated circuits; indium-based paste for thermal interfaces; and metal salt solutions used in the production of solar panels and other plating applications. In addition, Teck Resources Limited offers non-ferrous metal refining, metal alloying and casting, electro-winning and electro-refining, metal distilling, metal atomizing, metal salt producing, and metal recycling services for product development. Further, it provides industrial chemicals comprising copper arsenate, copper sulphate pentahydrate, ferrous granules, molten sulphur, sodium antimonate, sulphur dioxide, and sulphuric acid; ammonium sulphate solution and zinc sulphate solution; steelmaking coal; and fertilizers. The company has exploration operations in various countries of the Americas, the Asia Pacific, Europe, and Africa. Teck Resources Limited holds interest in oil sands development assets; wind power project; and a portfolio of copper, zinc, and gold exploration properties. It also owns interests in approximately 13 mines in Canada, the United States, Chile, and Peru, as well as 1 metallurgical complex in Canada. The company was formerly known as Teck Cominco Limited and changed its name to Teck Resources Limited in April 2009. Teck Resources Limited was founded in 1906 and is headquartered in Vancou ver, Canada.

Advisors' Opinion:
  • [By Ben Levisohn]

    Against that backdrop, Cowen’s Daniel Scott and Bryan Bergin have decided to cut their ratings on met coal producers Alpha Natural Resources, Walter Energy and Teck Resources (TCK) to Market Perform from Outperform. Scott and Bergin explain why:

10 Best Safest Stocks To Buy Right Now: Ishares Xinhua China 25 (FXI)

iShares FTSE/Xinhua China 25 Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the FTSE/Xinhua China 25 Index (the Index). The Index is designed to represent the performance of the largest companies in the China equity market that are available to international investors. The Index consists of Class H and Red Chip shares of 25 of the largest and most liquid Chinese companies. Securities in the Index are weighted based on the total market value of their shares. Each security in the Index is a constituent of the FTSE All-World Index. All of the securities in the Index trade on the Hong Kong Stock Exchange.

The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.

Advisors' Opinion:
  • [By Belinda Cao]

    The iShares FTSE China 25 Index Fund (FXI), the largest Chinese exchange-traded fund in the U.S., slid 0.9 percent April 5 to $35.64 in New York, the lowest level since Oct. 10. The ETF lost 3.5 percent in the week.

  • [By Jonathan Yates]

    China recently announced a series of economic reforms that are very market driven. The main exchange traded fund for China,�iShares China Large-Cap�(NYSE: FXI), is up more than 10 percent for the last month of market action.

  • [By Jeff Reeves]

    So if you want to play China, I advise a broad play via the SPDR S&P China ETF (GXC). It�� reasonably cheap with expenses of 0.59%, or $59 annually for every $10,000 invested. It�� also much more diversified with only three stocks allocated at over 3% of the fund and no pick over 7% allocation. That�� much safer than the more popular iShares FTSE China Large Cap ETF (FXI), whose top five holdings have a massive 40% allocation collectively.

10 Best Safest Stocks To Buy Right Now: Medtronic Inc (MDT)

Medtronic, Inc. (Medtronic), incorporated on April 23, 1957, is engaged in medical technology - alleviating pain, restoring health, and extending life for millions of people worldwide. As of April, 27, 2012, the Company functions in two operating segments that manufacture and sells device-based medical therapies. The Company's operating segments include Cardiac and Vascular Group, which consists of Cardiac Rhythm Disease Management (CRDM) and CardioVascular, and Restorative Therapies Group, which consists of Spinal, Neuromodulation, Diabetes and Surgical Technologies. Medtronic serves hospitals, physicians, clinicians, and patients in more than 120 countries worldwide. The Company's primary customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care programs and group purchasing organizations. In August 2013, Medtronic, Inc. announced the closing of the acquisition of Cardiocom. Effective September 3, 2013, Medtronic Inc acquired a 30% stake in NGC Medical SpA.

Cardiac Rhythm Disease Management

CRDM develops, manufactures, and markets products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure, including implantable devices, leads and delivery systems, products for the treatment of atrial fibrillation (AF), and information systems for the management of patients with CRDM devices. The Company's principal products offered by CRDM business include Implantable Cardiac Pacemakers (Pacemakers), Implantable Cardioverter Defibrillators (ICDs), Implantable Cardiac Resynchronization Therapy Devices (CRT-Ds and CRT-Ps), AF Products, Diagnostics and Monitoring Devices and Patient Management Tools. The Company's pacemaker systems are compatible with certain magnetic resonance imaging (MRI) machines. This includes the Revo MRI SureScan with United States Food and Drug Administration approval and the Advisa and Ensura MRI SureScan models with Conformite Europeene (CE)! Mark approval. Medtronic also continues to market the Adapta product family, which includes the Adapta, Versa, Sensia, and Relia models.

The Medtronic ICDs is the Protecta family with SmartShock technology, including the Lead Integrity Alert, a technology designed to improve the detection of lead fractures. Devices in the ICD family are the Protecta XT, Protecta, Cardia, and Egida models. Medtronic also continues to market the Secura and Maximo II devices. The Medtronic CRT-Ds is the Protecta family with SmartShock technology, including Protecta XT and Protecta, and the CRT-P devices are Consulta and Syncra. Medtronic also continues to market the Consulta, Cardia, Egida, and Maximo II CRT-D devices. In addition to these devices, Medtronic has an offering of left heart leads and delivery catheters with its Attain family of products. The Company's portfolio of AF products includes the Arctic Front Cardiac CryoAblation Catheter designed to treat paroxysmal AF by performing pulmonary vein isolation. The Company also offers the Reveal XT Insertable Cardiac Monitor, which is designed to identify and quantify episodes of AF. The Reveal DX and Reveal XT Insertable Cardiac Monitors devices are used to record the heart's electrical activity before, during, and after transient symptoms such as syncope and palpitations to help provide a diagnosis. It has a number of patient management tools, such as CareLink, Paceart, and CardioSight Service. CareLink enables patients to transmit data from their pacemaker, ICD, CRT-D, or Insertable Cardiac Monitors using a portable monitor that is connected to a standard telephone line or cellular network using the Medtronic M-Link accessory.

The Company competes with St. Jude Medical, Inc., Boston Scientific Corporation, Biotronik, Inc. and Sorin Group.

CardioVascular

CardioVascular is comprised of three businesses: Coronary, Endovascular and Peripheral, and Structural Heart. The Coronary business includes therapies to treat ! coronary ! artery disease (CAD) and hypertension. The products contained within this business include coronary stents and related delivery systems, along with a broad line of balloon angioplasty catheters, guide catheters, guidewires, diagnostic catheters, and accessories. The products offered by its Coronary business include Percutaneous Coronary Intervention (PCI) and Renal Denervation. The Endovascular and Peripheral business is comprised of a range of products and therapies to treat abdominal and thoracic aortic aneurysms and peripheral vascular disease (PVD). The Company's products include endovascular stent graft systems, embolic protection systems, and stent systems for the treatment of narrowed iliac arteries. The products offered by the Company's Endovascular and Peripheral business include Endovascular Stent Grafts and Peripheral Vascular Intervention (PVI). The Structural Heart business offers a range of products and therapies to treat a variety of heart valve disorders. The Company's products include products for the repair and replacement of heart valves, perfusion systems, positioning and stabilization systems for beating heart revascularization surgery, and surgical ablation products. The Company's principal products offered by its Structural Heart business include Heart Valves, Transcatheter Heart Valves, Arrested Heart Surgery, Beating Heart Surgery and Surgical Ablation.

The Company competes with Abbott Laboratories, Boston Scientific, and Johnson & Johnson, Cook, Inc., W. L. Gore & Associates, Inc., Endologix, Inc., C.R. Bard, Inc., Edwards LifeSciences Corporation, St. Jude, Terumo Medical Corporation and Sorin Group.

Spinal

The Company's Spinal business develops, manufactures, and markets a range of medical devices and implants used in the treatment of the spine and musculoskeletal system. The Company's products and therapies treat a range of conditions affecting the spine, including degenerative disc disease, spinal deformity, spinal tumours, fractures ! of the sp! ine, and stenosis. The Company's Spinal business also provides biologic solutions for the dental and orthopedic markets. The Company's Spinal products are used in spinal fusion of both the thoracolumbar region, referring to the mid to lower vertebrae, as well as of the cervical region, or upper spine and neck vertebrae. Products used to treat spinal conditions include rods, pedicle screws, hooks, plates, and interbody devices, as well as biologics products, primarily bone growth substitutes including bone graft extenders and structural allografts such as dowels and wedges. The products offered by the Company's Spinal business include Thoracolumbar Products, Cervical Products and Biologics Products.

The Company competes with DePuy Spine, Inc., Synthes, Inc., Stryker Corporation, NuVasive, Inc., Globus Medical, Inc., Zimmer, Inc., Alphatec Spine, Inc., Orthofix International N.V., Biomet, Inc. and Johnson & Johnson.

Neuromodulation

The Company's Neuromodulation business develops, manufactures, and markets medical devices for the treatment of chronic pain, movement disorders, psychological disorders, and urological, fecal, and gastroenterological disorders. The l products offered by the Company's Neuromodulation business includes Neurostimulators for Chronic Pain, Implantable Drug Delivery Systems, Deep Brain Stimulation (DBS) Systems and Urology, Fecal, & Gastroenterology Devices. The Company's portfolio of products includes the RestoreSensor (rechargeable), with the Company's AdaptiveStim technology, as well as the RestoreULTRA (rechargeable), RestoreADVANCED (rechargeable), and PrimeADVANCED (non-rechargeable) neurostimulation systems. The SynchroMed II Programmable Infusion System delivers small quantities of drug directly into the intrathecal space surrounding the spinal cord. These devices are used to treat chronic, intractable pain and severe spasticity associated with cerebral palsy, multiple sclerosis, spinal cord and traumatic brain injuries, and stroke.

DBS uses a surgically implanted medical device, similar to a cardiac pacemaker, to deliver carefully controlled electrical stimulation to precisely targeted areas in the brain. The Company's family of Activa Neurostimulators for DBS includes Activa SC (single-channel primary cell), Activa PC (dual channel primary cell), and Activa RC (dual channel rechargeable). The Company's therapeutic portfolio for urology and gastroenterology includes the InterStim Therapy System, which treats the symptoms of overactive bladder, urinary retention, and chronic fecal incontinence, and the Enterra Therapy System for the treatment of chronic nausea and vomiting caused by gastroparesis of diabetic or idiopathic origin for drug refractory patients.

The Company's competes with Boston Scientific, St. Jude., Urologix, Inc. and Allergan.

Diabetes

The Company's Diabetes business develops, manufactures, and markets advanced, integrated diabetes management solutions that include insulin pump therapy, continuous glucose monitoring systems, and therapy management software. The products offered by the Company's Diabetes business includes Integrated Diabetes Management Solutions, Professional CGM and CareLink Therapy Management Software. Outside the United States, the Company offers its Paradigm Veo System, an integrated system that includes a Low Glucose Suspend feature that automatically suspends insulin delivery when glucose levels become too low. In the United States, the Company offers the Paradigm Revel System, which incorporates new CGM features, including predictive alerts that can give early warning to people with diabetes so they can take action to prevent dangerous high or low glucose events. Medtronic offers physicians a Professional CGM product called the iPro CGM and iPro2 Professional CGM. The Company offers Web-based therapy management software solutions, including CareLink Personal software for patients and CareLink Pro software, to helps patients and their health care prov! iders con! trol their diabetes.

The Company competes with DexCom, Inc., Insulet Corporation, Johnson & Johnson and Roche Ltd.

Surgical Technologies

The Company's Surgical Technologies business develops, manufactures, and markets products and therapies to treat diseases and conditions of the ear, nose, and throat (ENT) and certain neurological disorders. In addition, the business develops, manufactures, and markets image-guided surgery and intra-operative imaging systems that facilitate surgical planning during precision cranial, spinal, sinus, and orthopedic surgeries. The products offered by the Company's Surgical Technologies business includes ENT, Neurological Technologies, Navigation and Advanced Energy. The ENT products treat diseases and conditions, such as NIM Nerve Monitoring Systems, Fusion ENT Navigation System, Hydrodebrider Endoscopic Sinus Irrigation System, Meniett Device for Meniere's Disease, Pillar Procedure for Snoring and Sleep Apnea, and Repose System for Obstructive Sleep Apnea. The Neurological Technologies products treat certain neurological disorders and conditions, such as Midas Rex Spine Shaver, the Midas Rex MR7 Pneumatic Platform, the Midas Rex Legend EHS High Speed Surgical Drill, the Strata Family of Adjustable Valves for the treatment of Hydrocephalus, Duet External Drainage & Monitoring System, the IPC System, and the Subdural Evacuating Port System.

The Navigation products are used in cranial, spinal, sinus, and orthopedic surgeries, such as the StealthStation S7 Navigation and i7 Integrated Navigation Systems, the O-Arm 2D/3D Surgical Imaging System, and the PoleStar Surgical MRI System. The products make up the Advanced Energy business: PEAK Surgery System, a tissue dissection system that consists of the PEAK PlasmaBlade and the PULSAR Generator and is cleared for use in a variety of settings, including ENT, plastic reconstructive and general surgery; and the Aquamantys System, which uses patented Transcollation technology to ! provide h! aemostatic sealing of soft tissue and bone and is cleared for use in a range of surgical procedures, including orthopedic surgery, spine, solid organ resection and thoracic procedures.

The Company competes with Gyrus ACMI, Stryker Corporation, Johnson & Johnson, Integra LifeSciences Holdings Corporation, BrainLAB, Inc., GE Healthcare, Siemens Medical Solutions USA, Inc., Philips Medical Systems, Covidien and ArthroCare Corporation.

Advisors' Opinion:
  • [By John Udovich]

    As for the ETFs, the iShares Dow Jones US Medical Device ETF�tracks the Dow Jones U.S. Select Medical Equipment Index while the SPDR S&P Health Care Equipment ETF tracks the S&P Health Care Equipment Select Industry Index, but investors should be aware that the late ETF appears less concentrated than the former, which has over 11% of its portfolio invested in Medtronic, Inc (NYSE: MDT).

10 Best Safest Stocks To Buy Right Now: ProShares UltraShort S&P500 (SDS)

ProShares UltraShort S&P500 (the Fund), formerly UltraShort S&P500 ProShares, seeks daily investment results that correspond to twice the inverse daily performance of the S&P 500 Index. The S&P 500 Index is a measure of large-cap United States stock market performance. The S&P 500 Index is a capitalization-weighted index of 500 United States operating companies and real estate investment trusts (REITs) selected by an S&P committee through a non-mechanical process that factors criteria, such as liquidity, price, market capitalization, financial viability and public float.

The S&P 500 Index is a price return index. Reconstitution of the Index occurs both on a quarterly and on an ongoing basis. The Fund takes positions in securities and/or financial instruments that, in combination, should have similar daily return characteristics as 200% of the daily return of the index. The Fund�� investment advisor is ProShare Advisors LLC.

Advisors' Opinion:
  • [By John Udovich]

    The so-called Hindenburg Omen predicting a major market crash is increasingly popping into the headlines; but regardless of whether or not you believe in the prophecy,�short ETFs like ProShares UltraShort S&P500 ETF (NYSEARCA: SDS), ProShares Short Dow30 ETF (NYSEARCA: DOG) and�ProShares UltraShort QQQ ETF (NYSEARCA: QID) can off you some protection or insurance. We have also periodically added short ETFs to our�SmallCap Network Elite Opportunity (SCN EO) portfolio as a�hedge against short-term�market downturns or�short-term trend reversals and right now, we have the ProShares UltraShort S&P500 ETF in our portfolio.

10 Best Safest Stocks To Buy Right Now: EMC Corporation(EMC)

EMC Corporation develops, delivers, and supports the information and virtual infrastructure technologies and solutions. The company offers enterprise storage systems and software, which are deployed in storage area networks (SAN), networked attached storage (NAS), unified storage combining NAS and SAN, object storage, and/or direct attached storage environments, as well as provides backup and recovery, and disaster recovery and archiving solutions. It also offers information security solutions in various areas, such as enterprise governance, risk and compliance, data loss prevention, security information management, continuous network monitoring, fraud protection, identity assurance and access control, and encryption and key management. In addition, the company provides information intelligence software, solutions, and services, including EMC Captiva for intelligent enterprise capture; EMC Document Sciences for customer communications management; EMC Kazeon for e-discovery ; EMC Documentum xCP for building business solutions and an action engine for big data; and the EMC Documentum platform for managing and delivering enterprise information. Further, it offers virtual and cloud infrastructure products, such as virtualization and virtualization-based cloud infrastructure solutions that address a range of IT problems, as well as facilitate access to cloud computing capacity, business continuity, software lifecycle management, and corporate end-user computing device management In addition, the company provides consulting, technology deployment, managed, customer support, and training and certification services. EMC Corporation markets its products through direct sales and through multiple distribution channels in North America, Latin America, Europe, the Middle East, South Africa, and the Asia Pacific region. The company was founded in 1979 and is headquartered in Hopkinton, Massachusetts.

Advisors' Opinion:
  • [By Jon C. Ogg]

    EMC Corp. (NYSE: EMC) was downgraded to Equal Weight from Overweight with a new $28 price target by Barclays.

    Facebook Inc. (NASDAQ: FB) was upgraded to Buy from Neutral, and the price target was lifted to $55 from $32, at Citigroup.

  • [By jaggom]

    Shares of VMware (VMW), the virtualization infrastructure provider increased more than 20% this year thanks to several catalysts enjoyed by the company. In addition, the wide customer base of VMware�� parent EMC�� (EMC) and growing suite of solutions is also positive indicator for VMware investors who can expect the company�� outperformance to continue. Going forward, VMware should continue to perform robustly with the continued growth in data consumption across the globe and growth of virtualization.

10 Best Safest Stocks To Buy Right Now: Radioshack Corporation(RSH)

RadioShack Corporation engages in the retail sale of consumer electronic goods and services through its RadioShack store chain and kiosk operations. Its products include postpaid and prepaid wireless handsets and communication devices, such as scanners and global positioning system (GPS) products; home entertainment, wireless, music, computer, video game, and GPS accessories; media storage, power adapters, digital imaging products, and headphones; home audio and video end-products, personal computing products, residential telephones, and voice over Internet protocol products; digital cameras, digital music players, toys, satellite radios, video gaming hardware, camcorders, and general radios; general and special purpose batteries and battery chargers; and wires and cables, connectivity products, components and tools, and hobby products. The company also provides consumers access to third-party services, such as prepaid wireless airtime and extended service plans in its ser vice platform. In addition, it manufactures various products, including telephones, antennas, wires, and cable products, as well as various hard-to-find parts and accessories for consumer electronics products; and provides repair services. As of March 31, 2011, the company operated 4,467 company-operated retail stores under the RadioShack brand name in the United States; and 1,304 kiosks located in Target and Sam?s Club stores. As of December 31, 2010, it operated 211 company-operated stores under the RadioShack brand, 9 dealers, and 1 distribution center in Mexico; a network of 1,207 RadioShack dealer outlets, including 34 located outside of North America; and 4 distribution centers in the United States. Further, the company sells its products through its Website, radioshack.com. RadioShack Corporation was founded in 1899 and is based in Fort Worth, Texas.

Advisors' Opinion:
  • [By Steven Russolillo]

    RadioShack Corp (RSH). just tumbled below the stock market’s version of the Mendoza Line.

    Shares dropped under $1 Friday morning for the first time ever, as the beleaguered electronics retailer continues to struggle and bankruptcy rumors swirl. Early this month the company reported ugly quarterly numbers that sparked some dire outlooks from Wall Street analysts, including one who slashed his price target to $0 and said the shares were worthless.

  • [By Luke Jacobi]

    RadioShack (NYSE: RSH) reported that discussions with creditors and a major vendor to modify a “commercial relationship” have been unproductive. This comes shortly after the company suggested it may have to declare bankruptcy, a course of action Wall Street has speculated on for years.

  • [By Philip Springer]

    What’s this week’s big story for investors?

    Candidate #1: RadioShack (NYSE: RSH) said it will close up to 1,100 of its nearly 5,200 US stores amid widening losses. The company also announced that revenue in the fourth quarter of 2013 fell 20 percent from year-earlier levels.

    It doesn’t matter whether the latest announcement is in addition to or merely an expansion of the company’s Feb. 5 statement that it would close 500 stores. That, in turn, shortly followed the beleaguered company’s $4 million expenditure for a widely praised but clearly ill-timed 30-second ad during the Super Bowl.

    Also this week, Radio Shack agreed to pay its top executives “retention” bonuses, saying their skills are critical to the company�� comeback plan. CEO Joe Magnacca will get a $500,000 payment, while other executives will receive $187,500 to $275,000.

    The stock currently trades around $2, down from its 1999 peak of $61.

    No, that’s not the week’s big story. But it was too good to ignore.

    Candidate #2: The current bull market celebrates its fifth birthday this week, with the Standard & Poor’s 500 delivering a total return of about 175 percent during that time.

    Since 1921, the median bull market has been 50 months long and has delivered 115 percent in price appreciation. So this market is older and better than most. Still, the conditions aren’t yet present to suggest the end is near. Indeed, Wednesday’s advance, the best of the year to date, was exceptional for both its breadth and heavy volume.

    The five-year anniversary also means that stocks, mutual funds, exchange-traded funds, closed-end funds and so on will boast very good five-year returns. Don’t be overly impressed. Reason: Almost everybody will be a winner. (Other than Radio Shack.) But you should dig deeper: Comparisons will be useful to sort out leaders and laggards for potential investme

10 Best Safest Stocks To Buy Right Now: Hibbett Sports Inc.(HIBB)

Hibbett Sports, Inc. operates sporting goods stores in small to mid-sized markets primarily in the southeast, southwest, Mid-Atlantic, and Midwest regions of the United States. Its stores offer an assortment of merchandise, including athletic footwear, team sports equipment, athletic and fashion apparel, and related accessories. The company also provides its merchandise directly to educational institutions and youth associations. As of January 28, 2012, it operated 832 stores consisting of 812 Hibbett Sports stores, 19 smaller-format Sports Additions athletic shoe stores, and 1 larger-format Sports & Co. superstore in 26 states. The company was formerly known as Hibbett Sporting Goods, Inc. and changed its name to Hibbett Sports, Inc. in January 2007. Hibbett Sports, Inc. was founded in 1945 and is headquartered in Birmingham, Alabama.

Advisors' Opinion:
  • [By Maria Armental and Tess Stynes var popups = dojo.query(".socialByline .popC"); ]

    Hibbett Sports Inc.(HIBB) posted an 8.3% rise in fiscal first-quarter earnings, with the sporting-goods retailer saying it is benefiting from stronger demand in footwear and apparel.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Hibbett Sports (Nasdaq: HIBB  ) , whose recent revenue and earnings are plotted below.

  • [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]

    Hibbett Sports Inc.(HIBB) posted an increase in fiscal fourth-quarter sales, but its bottom line was hit by higher costs. The company’s results fell below Wall Street expectations, sending shares down 4.5% to $55.25 premarket.

  • [By Peter Graham]

    The Q1 2014�earnings report for Dicks Sporting Goods Inc (NYSE: DKS), a competitor of other sporting goods stocks like Big 5 Sporting Goods Corporation (NASDAQ: BGFV) and�Hibbett Sports, Inc (NASDAQ: HIBB), is scheduled for before the market opens on Tuesday, May 20. Aside from the Dicks Sporting Goods's earnings report, it should be said that Big 5 Sporting Goods Corporation reported Q1 2014 earnings on April 29 (earnings were weak and they hinted at continued troubles ahead due the weak sales trends) while Hibbett Sports, Inc will report Q1 2015 earnings before the market opens on Friday, May 23.�However, Dicks Sporting Goods is heading into earnings this week with positive coverage form analysts.

No comments:

Post a Comment